Nalaganje...
Recent advances in the generation of human monoclonal antibody
The use of monoclonal antibodies (mAbs) has now gained a niche as an epochal breakthrough in medicine. Engineered antibodies (Abs) currently account for over 30% of biopharmaceuticals in clinical trials. Several methods to generate human mAbs have evolved, such as (1) immortalization of antigen-spec...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Netherlands
2007
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2104546/ https://ncbi.nlm.nih.gov/pubmed/19002994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-007-9072-5 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|